Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RSV infection observation cohort | Other | No intervention; Epidemiological Study. Participants will receive standard care based on local clinical practice |
| Measure | Description | Time Frame |
|---|---|---|
| the incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the study site | infection incidence | 1 year |
| the Incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the hospital | infection incidence | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| the clinical characteristics of RSV infection | symptoms description and scoring of RSV infection | 1 year |
| Clinical outcome and relevant risk factor of RSV infection | Clinical outcome and relevant risk factor of RSV infection |
Not provided
Inclusion Criteria:
1) Aged ≥ 18 years old. 2) Receiving hematopoietic stem cell transplantation; OR being diagnosed with hematological malignancies (including but not limited to leukemia, lymphoma, and multiple myeloma) and receiving chemotherapy.
3) New onset of respiratory symptoms; OR exacerbation of existing chronic respiratory symptoms (such as previously diagnosed chronic runny nose, seasonal allergies, chronic lung disease, etc.).
4) Willing to sign an informed consent form, able to understand and willing to follow the study protocol.
Exclusion Criteria:
Not provided
Not provided
Not provided
adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients have new onset or worsen of respiratory signs/syndromes and presented the study site.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Erlie Jiang, MD | Contact | +86-15122538106 | jiangerlie@ihcams.ac.cn |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences | Recruiting | Tianjin | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 year |
| Virological characteristics of RSV infection from D1 through D28, D42 or even longer | Clinical outcome and relevant risk factor of RSV infection | 1 year |
| ID | Term |
|---|---|
| D018357 | Respiratory Syncytial Virus Infections |
| ID | Term |
|---|---|
| D018186 | Pneumovirus Infections |
| D018184 | Paramyxoviridae Infections |
| D018701 | Mononegavirales Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D007239 | Infections |
Not provided
Not provided